UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 18, 2025

BIP Ventures Evergreen BDC

(Exact name of Registrant as Specified in Its Charter)

Delaware		000-56550		93-6632897
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

3575 Piedmont Rd NE Building 15, Suite 730 Atlanta, GA		30305
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: (404) 410-6476

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: None

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
N/A		N/A		N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

Recent BIP Ventures Evergreen BDC Transaction Highlights

On June 18, 2025, BIP Ventures Evergreen BDC (the “Company”) and an affiliated fund entered into binding purchase agreements with third-party investors of ChartSpan Medical Technologies, Inc. (“ChartSpan”). The Company and an affiliated fund have agreed to purchase the investors’ existing shares of ChartSpan in a secondary transaction. As the transaction is an off-market transaction, the Company expects the investment to be immediately accretive to the Company when funded. The amount that will be purchased by the Company and affiliated fund is $20 million in aggregate. The amounts allocated to the Company and the affiliated fund are dependent on various matters, including capital availability at the dates of funding. The Company funded $7 million on June 18, 2025. The unfunded amounts will be funded by the Company and the affiliated fund through the remainder of the year-ending December 31, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	BIP Ventures Evergreen BDC

Date: June 20, 2025	By:	/s/ Mark Buffington
		Mark Buffington
		Chairman of the Board and Chief Executive Officer

BIP Ventures Evergreen BDC 8-K